Lipid-Based Drug Delivery Systems for Diseases Managements

82Citations
Citations of this article
152Readers
Mendeley users who have this article in their library.

Abstract

Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active agents. The description of the physicochemical properties, formulation methods, characteristics, mechanisms of action, and large-scale manufacturing of liposomes as delivery systems are deeply discussed. The benefits, toxicity, and limitations of the use of liposomes in pharmacotherapeutics including in diagnostics, brain targeting, eye and cancer diseases, and in infections are provided. The experimental approaches that may reduce, or even bypass, the use of liposomal drug drawbacks is described. The application of liposomes in the treatment of numerous diseases is discussed.

Cite

CITATION STYLE

APA

Gbian, D. L., & Omri, A. (2022, September 1). Lipid-Based Drug Delivery Systems for Diseases Managements. Biomedicines. MDPI. https://doi.org/10.3390/biomedicines10092137

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free